Acura (ACUR) advised by Pfizer (PFE) Oxecta is commercially available, receives tiered royalties of 5-25% on net sales
Go back to Acura (ACUR) advised by Pfizer (PFE) Oxecta is commercially available, receives tiered royalties of 5-25% on net sales| ACURA PHARMACEUTICALS, Inc. (AMEX: ACUR) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $3.52 | |||
| Open | $0.00 | 52 Week Low | $0.86 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-0.29 | |||
| Volume | 71 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 37,094,598 | |||||
